ÂÜÀòÂÒÂ×

The Leadership Team at Foghorn Therapeutics is responsible for setting the strategic direction and overseeing the company's initiatives in discovering and developing innovative therapies targeting the chromatin regulatory system. This team, composed of executives across various functions such as scientific research, investor relations, legal affairs, and human resources, collaborates to ensure the successful advancement of drug candidates, guide corporate communications, foster a strong company culture, and maintain compliance with regulatory standards. Their collective expertise drives the mission to unlock new treatment opportunities for patients by leveraging the Gene Traffic Control platform.